BIOCON
Back to Balance Sheet
|
BIOCON Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹100 Cr | ₹74 Cr | ₹81 Cr | ₹-241 Cr | ₹-275 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of BIOCON ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹100 Cr |
| Mar2024 | ₹74 Cr |
| Mar2023 | ₹81 Cr |
| Mar2022 | ₹-241 Cr |
| Mar2021 | ₹-275 Cr |
How is Deferred Tax Assets / Liabilities of BIOCON Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹100 Cr | 34.77 | |
| Mar2024 | ₹74 Cr | -8.17 | |
| Mar2023 | ₹81 Cr | Positive | |
| Mar2022 | ₹-241 Cr | Negative | |
| Mar2021 | ₹-275 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of BIOCON
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BIOCON | ₹61,634.7 Cr | 2.5% | 0.7% | 0.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹407,827.0 Cr | -0.5% | 1.8% | -2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹163,363.0 Cr | -0.3% | -1.3% | 4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹144,193.0 Cr | 4.4% | 6% | 27.7% | Stock Analytics | |
| CIPLA | ₹109,519.0 Cr | 1% | -3% | -8.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,940.0 Cr | 1.1% | 8% | 3.8% | Stock Analytics | |
BIOCON Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BIOCON | 2.5% |
0.7% |
0.2% |
| SENSEX | -0.9% |
-0.1% |
7% |
You may also like the below Video Courses